About | Support Us | Contact
Research Portfolio

Funding Opportunities

Join our Mailing List
Join our mailing list to be notified of new funding opportunities.

Your Email

To receive information about funding opportunities, events, and program updates.
Home Page > Investigator Page

Ching-Hsien Chen,

University of California, Davis # of Grants: 4

Grants
Targeting aggressive kidney cancer cells deficient in a metabolic enzyme 2019 (Cycle 29) $937,500
Cancer High Impact Research Project Award
Targeting phospho-MARCKS in smoke-mediated lung cancer 2014 (Cycle 23) $91,436
Early Diagnosis/Pathogenesis Postdoctoral Fellowship Awards
Tackling Stem-Like Cells in Tobacco Smoke-Mediated Cancer Ma 2018 (Cycle 27) $750,000
Cancer New Investigator Awards
Therapeutic targeting to inhibit lung fibrosis progression 2019 (Cycle 28) $925,286
Pulmonary Disease High Impact Research Project Award
Publications
Targeting myristoylated alanine-rich C kinase substrate phosphorylation site domain in lung cancer. Mechanisms and therapeutic implications
Periodical: American Journal of Respiratory and Critical Care Medicine Index Medicus:
Authors: Chen CH, Statt S, Chiu CL, et al ART
Yr: 2014 Vol: 190 Nbr: 10 Abs: Pg: 1127-1138
Elevated MARCKS phosphorylation contributes to unresponsiveness of breast cancer to paclitaxel treatment
Periodical: Oncotarget Index Medicus:
Authors: Chen CH, Cheng CT, Yuan Y, et al ART
Yr: 2015 Vol: 6 Nbr: 17 Abs: Pg: 15194-15208
HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual_x000D_ mechanisms
Periodical: Oncogene Index Medicus:
Authors: Chen CH, Chang WH, Su KY, Ku WH, Chang GC, Hong QS, Hsiao YJ, Chen HC, Chen HY, Wu R, Yang ART
Yr: 2016 Vol: Nbr: Abs: Pg:
Targeting myristoylated alanine-rich C kinase substrate phosphorylation site domain in lung cancer. Mechanisms and therapeutic implications
Periodical: American Journal of Respiratory and Critical Care Medicine Index Medicus:
Authors: Chen CH, Statt S, Chiu CL, et al ART
Yr: 2014 Vol: 190 Nbr: 10 Abs: Pg: 1127-1138
Elevated MARCKS phosphorylation contributes to unresponsiveness of breast cancer to paclitaxel treatment
Periodical: Oncotarget Index Medicus:
Authors: Chen CH, Cheng CT, Yuan Y, et al ART
Yr: 2015 Vol: 6 Nbr: 17 Abs: Pg: 15194-15208
HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual_x000D_ mechanisms
Periodical: Oncogene Index Medicus:
Authors: Chen CH, Chang WH, Su KY, Ku WH, Chang GC, Hong QS, Hsiao YJ, Chen HC, Chen HY, Wu R, Yang ART
Yr: 2016 Vol: Nbr: Abs: Pg:
Cigarette Smoking-Mediated Macrophage Reprogramming: Mechanistic Insights and Therapeutic Implications. J Nat Sci., 2018 4 11
Periodical: Index Medicus:
Authors: Yang DC and Chen CH ART
Yr: Vol: Nbr: Abs: Pg:
Cigarette Smoking-Mediated Macrophage Reprogramming: Mechanistic Insights_x000D_ and Therapeutic Implications. J Nat Sci., 2018; 4(11)._x000D_
Periodical: Index Medicus:
Authors: Yang DC and Chen CH ART
Yr: Vol: Nbr: Abs: Pg:
Cigarette Smoking-Mediated Macrophage Reprogramming: Mechanistic Insights and Therapeutic Implications. J Nat Sci., 2018 4 11
Periodical: Index Medicus:
Authors: Yang DC and Chen CH ART
Yr: Vol: Nbr: Abs: Pg:
Cigarette Smoking-Mediated Macrophage Reprogramming: Mechanistic Insights_x000D_ and Therapeutic Implications. J Nat Sci., 2018; 4(11)._x000D_
Periodical: Index Medicus:
Authors: Yang DC and Chen CH ART
Yr: Vol: Nbr: Abs: Pg:
Cigarette Smoking-Mediated Macrophage Reprogramming: Mechanistic Insights_x000D_ and Therapeutic Implications. J Nat Sci., 2018; 4(11).
Periodical: Index Medicus:
Authors: Yang DC and Chen CH ART
Yr: Vol: Nbr: Abs: Pg:
Cigarette Smoking-Mediated Macrophage Reprogramming: Mechanistic Insights_x000D_ and Therapeutic Implications. J Nat Sci., 2018; 4(11).
Periodical: Index Medicus:
Authors: Yang DC and Chen CH ART
Yr: Vol: Nbr: Abs: Pg: